# F2-LOR-1009-AUTH-UNBLOCK-001 Product Receipt

Date: 2026-08-09

State: AUTHORITY FILING PENDING INDEPENDENT VERIFICATION. NO PRODUCT SOURCE,
DATA, PROVIDER, ENVIRONMENT, DEPLOYMENT, CANARY, OR USER MUTATION.

## Founder authorization

- Ticket: `F2-LOR-1009-AUTH-UNBLOCK-001`
- Supplied file:
  `/Users/brianb/.codex/attachments/37120691-54b1-48b2-8a78-ea29e218078c/pasted-text.txt`
- SHA-256:
  `8611c9dc8e34d2f4733271b7e33cba50bfa031444e5a8a4871cebd11460f1ccb`
- Production-continuation ticket: `F2-LOR-1009-PRODUCTION-RELEASE-MEGARUN`
- Production-continuation SHA-256:
  `e94f066005b6d60e081e26275c62495219575660c5742e9388aa17c541090534`

Brian expressly authorized repair of stale MissionMed OS authority state,
filing of exact implementation and conditional release authority, fresh
independent verification, and automatic resumption from the first unpassed
F2-LOR-1009 gate after PASS.

## Product baseline

- Repository: `https://github.com/brinyu13/missionmed-hq.git`
- Authority branch: `codex/f2-lor-1005-production-beta`
- Exact pre-implementation commit:
  `9a2d7adaa4a3ff3cb061120c4bb0fff42263e8d8`
- Remote branch matched the local commit before this evidence-only change.
- Existing draft pull request: `#23`
- Canonical prototype:
  `/Users/brianb/MissionMed/F2-LOR-1003-functional-prototype.html`
- Canonical prototype SHA-256:
  `8560559341895f2973c51bdf7d7ba28ba7a9890d70c6bc6eb5976fc67371e037`

## Authority filing

The corresponding control-plane decision is:

`/Users/brianb/MissionMed_OS/decisions/DR-023_f2_lor_1009_authority_unblock_and_bounded_production_release.md`

DR-023 is deliberately fail-closed. Product-source mutation becomes executable
only when its committed MissionMed OS filing is pushed to canonical `main` and
a fresh non-builder read-only verifier returns PASS against that pushed commit.

After that PASS, implementation must begin on branch
`codex/f2-lor-1009-production-release` in the isolated worktree
`/Users/brianb/MissionMed_worktrees/F2-LOR-1009`, created from the exact
pre-implementation commit above. This evidence branch is not the authorized
implementation branch.

## Procedural variance

The disclosed read-command variance is preserved without a retroactive
compliance claim. Non-mutating `sed` reads occurred; one stopped reviewer also
reported `pwd` and `command -v`. Available evidence showed no state mutation
from those reads. The Founder ticket authorizes recording and resolving the
variance through the pushed filing and fresh verification; it does not erase
or rewrite the historical record.

## Current controls

- F2-LOR-1003 and F2-LOR-1004 remain the frozen product and fidelity law.
- DR-019 controls later privacy, access, retention, AI, canary, and release law.
- DR-022 remains the verified digest/lifecycle correction record.
- The Node runtime at `missionmed-hq/server.mjs` is the repository-native
  application owner identified by current evidence.
- Exact database, provider, staging, production-service, backup, restore, and
  rollback targets remain unverified and therefore unmutated.
- No secret value was requested, read, printed, or written.
- Unrelated user work is outside scope and preserved.

## Files changed by this product evidence commit

Only this authority-unblock evidence directory is intended to change. No
application source, test, package, lockfile, migration, WordPress, Matrix,
configuration, or deployment file is included.

## Next gate

1. Commit and push this evidence-only receipt.
2. Commit and push DR-023 plus the exact MissionMed OS registry, passport,
   handoff, and generated-current-state integration.
3. Obtain fresh inherited-context-free independent PASS.
4. File the PASS and activate the conditional implementation tranche.
5. Resume F2-LOR-1009 from its first unpassed gate; production remains closed
   until every later release condition is genuinely satisfied.
